PATEL DINESH V PH D

Average Profitability
243.28%
Insider Buys Quantity
1
Insider Buys Sum
$337,000.00
Insider Sells Quantity
13
Insider Sells Sum
$10.76M

Insider Activity of PATEL DINESH V PH D

According to the SEC Form 4 filings, PATEL DINESH V PH D, being in a position of

  1. President and CEO at Protagonist Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 190000 shares for $7.57M,
    over all time since 2017-12-20, has bought 60000 shares for $337,000, and sold 362614 shares for $10.76M.

The largest purchase of all time was on 2019-12-03 and amounted to 60000 shares of Protagonist Therapeutics, Inc. for $337,000.

The largest sale of all time was on 2024-11-25 and amounted to 78520 shares of Protagonist Therapeutics, Inc. for $3.69M.

Biography of PATEL DINESH V PH D

No biography is available at this moment.

2024-11-26SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
21,480
0.0373%
$46.25$993,450-7.52%
2024-11-25SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
78,520
0.1349%
$46.96$3.69M-8.91%
2024-06-07SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
35,000
0.0603%
$35.19$1.23M+20.4%
2024-04-01SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
25,000
0.0429%
$28.31$707,750+42.79%
2024-03-01SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
30,000
0.051%
$31.62$948,600+11.73%
2023-12-13SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
75,000
0.1305%
$20.08$1.51M+54.72%
2021-12-21SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
15,000
0.0311%
$32.14$482,171-70.97%
2021-01-19SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
24,846
0.0557%
$24.60$611,105+31.22%
2019-12-03PurchaseProtagonist Therapeutics, Inc.
PTGX
President and CEO
60,000
0.2602%
$5.62$337,000+243.28%
2019-08-06SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
21,584
0.0731%
$8.85$191,070+5.68%
2019-03-01SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
4,366
0.0172%
$8.03$35,059+28.72%
2019-02-06SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
21,818
0.0893%
$7.74$168,820+38.82%
2017-12-21SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
8,210
0.0464%
$19.56$160,570-55.14%
2017-12-20SaleProtagonist Therapeutics, Inc.
PTGX
President and CEO
1,790
0.0102%
$19.55$34,987-54.63%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.